FDA 483 - Precision Science Inc - October 24, 2025

Precision Science Inc, a contract drug manufacturer in Phoenix, AZ, received an FDA Form 483 for significant deficiencies observed during an inspection. The findings highlight inadequate equipment qualification, poor maintenance and cleaning procedures for manufacturing equipment, and critical gaps in computer system controls and data integrity. These issues collectively indicate a lack of robust quality control over the production of Type A medicated articles and Type C medicated feed.